USD 0.9
(1.79%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 7.62 Million USD | -4.64% |
2020 | 7.99 Million USD | -32.61% |
2019 | 11.86 Million USD | 262.97% |
2018 | 3.26 Million USD | 119.99% |
2017 | 1.48 Million USD | 38.0% |
2016 | 1.07 Million USD | 55.95% |
2015 | 690.15 Thousand USD | -41.62% |
2014 | 1.18 Million USD | 13.27% |
2013 | 1.04 Million USD | -35.39% |
2012 | 1.61 Million USD | 174.66% |
2011 | 588.07 Thousand USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | -100.0% |
2003 | 7660.00 USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | -100.0% |
2000 | 88.24 Thousand USD | 100.94% |
1999 | 43.91 Thousand USD | 36.08% |
1998 | 32.27 Thousand USD | 21.54% |
1997 | 26.55 Thousand USD | 0.0% |
1996 | - USD | -100.0% |
1995 | 28.42 Thousand USD | 6.52% |
1994 | 26.68 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 1.00 USD | 0.0% |
2024 Q2 | - USD | -16800100.0% |
2023 Q2 | 3.39 Million USD | 339899900.0% |
2023 FY | - USD | 0.0% |
2023 Q1 | 1.00 USD | 0.0% |
2023 Q3 | 632 Thousand USD | -81.41% |
2023 Q4 | - USD | -100.0% |
2022 Q4 | - USD | -100.0% |
2022 Q3 | 6.7 Million USD | 8.96% |
2022 Q2 | 6.15 Million USD | -31.42% |
2022 FY | - USD | -100.0% |
2022 Q1 | 8.96 Million USD | 17.65% |
2021 Q2 | 7.57 Million USD | 3.1% |
2021 FY | 7.62 Million USD | -4.64% |
2021 Q3 | 7.36 Million USD | -2.8% |
2021 Q1 | 7.34 Million USD | -8.1% |
2021 Q4 | 7.62 Million USD | 3.53% |
2020 Q2 | 10.17 Million USD | -30.36% |
2020 Q1 | 14.6 Million USD | 23.16% |
2020 Q3 | 9.93 Million USD | -2.36% |
2020 Q4 | 7.99 Million USD | -19.52% |
2020 FY | 7.99 Million USD | -32.61% |
2019 Q2 | 7.49 Million USD | 51.23% |
2019 FY | 11.86 Million USD | 262.97% |
2019 Q1 | 4.95 Million USD | 51.66% |
2019 Q4 | 11.86 Million USD | 12.61% |
2019 Q3 | 10.53 Million USD | 40.54% |
2018 Q2 | 1.88 Million USD | 16.02% |
2018 Q3 | 2.37 Million USD | 26.46% |
2018 Q4 | 3.26 Million USD | 37.4% |
2018 Q1 | 1.62 Million USD | 9.12% |
2018 FY | 3.26 Million USD | 119.99% |
2017 FY | 1.48 Million USD | 38.0% |
2017 Q4 | 1.48 Million USD | 14.83% |
2017 Q1 | 1.33 Million USD | 24.37% |
2017 Q2 | 1.41 Million USD | 5.63% |
2017 Q3 | 1.29 Million USD | -8.52% |
2016 FY | 1.07 Million USD | 55.95% |
2016 Q1 | 957.43 Thousand USD | 38.73% |
2016 Q2 | 883.65 Thousand USD | -7.71% |
2016 Q3 | 843.39 Thousand USD | -4.56% |
2016 Q4 | 1.07 Million USD | 27.62% |
2015 Q2 | 1.24 Million USD | 30.19% |
2015 Q3 | 870.05 Thousand USD | -30.32% |
2015 Q4 | 690.15 Thousand USD | -20.68% |
2015 Q1 | 959.18 Thousand USD | -18.86% |
2015 FY | 690.15 Thousand USD | -41.62% |
2014 Q2 | 1.45 Million USD | 57.82% |
2014 FY | 1.18 Million USD | 13.27% |
2014 Q1 | 920.68 Thousand USD | -11.78% |
2014 Q3 | 1.01 Million USD | -30.35% |
2014 Q4 | 1.18 Million USD | 16.82% |
2013 Q4 | 1.04 Million USD | -9.06% |
2013 FY | 1.04 Million USD | -35.39% |
2013 Q3 | 1.14 Million USD | -23.8% |
2013 Q2 | 1.5 Million USD | 12.57% |
2013 Q1 | 1.33 Million USD | -17.17% |
2012 Q2 | 820.24 Thousand USD | 51.15% |
2012 FY | 1.61 Million USD | 174.66% |
2012 Q1 | 542.66 Thousand USD | -7.72% |
2012 Q3 | 955.12 Thousand USD | 16.44% |
2012 Q4 | 1.61 Million USD | 69.11% |
2011 FY | 588.07 Thousand USD | 0.0% |
2011 Q4 | 588.07 Thousand USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q1 | - USD | -100.0% |
2004 Q2 | - USD | 0.0% |
2004 FY | - USD | -100.0% |
2004 Q4 | - USD | 0.0% |
2003 Q3 | 30.86 Thousand USD | 17.71% |
2003 Q4 | 7660.00 USD | -75.18% |
2003 Q2 | 26.22 Thousand USD | -50.54% |
2003 Q1 | 53.01 Thousand USD | 0.0% |
2003 FY | 7660.00 USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | 88.18 Thousand USD | -0.07% |
2001 FY | - USD | -100.0% |
2001 Q2 | - USD | -100.0% |
2001 Q3 | - USD | 0.0% |
2000 Q4 | 88.24 Thousand USD | 65.53% |
2000 Q3 | 53.3 Thousand USD | 3.02% |
2000 Q2 | 51.74 Thousand USD | 0.0% |
2000 Q1 | - USD | -100.0% |
2000 FY | 88.24 Thousand USD | 100.94% |
1999 Q4 | 43.91 Thousand USD | 0.0% |
1999 FY | 43.91 Thousand USD | 36.08% |
1998 FY | 32.27 Thousand USD | 21.54% |
1997 FY | 26.55 Thousand USD | 0.0% |
1996 FY | - USD | -100.0% |
1995 FY | 28.42 Thousand USD | 6.52% |
1994 FY | 26.68 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | 100.0% |
Safety Shot Inc | 1.86 Million USD | 100.0% |
Bright Green Corporation | - USD | NaN% |
Embecta Corp. | 152.1 Million USD | 100.0% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 100.0% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 100.0% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 100.0% |
Dynavax Technologies Corporation | 53.29 Million USD | 100.0% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 100.0% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 100.0% |
Pacira BioSciences, Inc. | 104.35 Million USD | 100.0% |
PainReform Ltd. | - USD | NaN% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 100.0% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 100.0% |
SCYNEXIS, Inc. | - USD | NaN% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | 100.0% |
Journey Medical Corporation | 10.2 Million USD | 100.0% |
Alpha Teknova, Inc. | 11.59 Million USD | 100.0% |
Procaps Group, S.A. | 96.83 Million USD | 100.0% |
Theratechnologies Inc. | 6.06 Million USD | 100.0% |
Harrow Health, Inc. | 10.86 Million USD | 100.0% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 100.0% |
Biofrontera Inc. | 10.9 Million USD | 100.0% |
DURECT Corporation | 2.21 Million USD | 100.0% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 100.0% |
Cronos Group Inc. | 30.33 Million USD | 100.0% |
OptiNose, Inc. | 8.05 Million USD | 100.0% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | 100.0% |
Kala Pharmaceuticals, Inc. | - USD | NaN% |
RedHill Biopharma Ltd. | 5.69 Million USD | 100.0% |
Organogenesis Holdings Inc. | 28.25 Million USD | 100.0% |
Guardion Health Sciences, Inc. | 2.67 Million USD | 100.0% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 100.0% |
Radius Health, Inc. | 278.64 Million USD | 100.0% |
Universe Pharmaceuticals INC | 3.34 Million USD | 100.0% |
ProPhase Labs, Inc. | 3.84 Million USD | 100.0% |
Phibro Animal Health Corporation | 265.91 Million USD | 100.0% |
Procaps Group S.A. | 96.83 Million USD | 100.0% |
Alvotech | 74.43 Million USD | 100.0% |
Viatris Inc. | 3.46 Billion USD | 100.0% |
Rockwell Medical, Inc. | 5.87 Million USD | 100.0% |
Aytu BioPharma, Inc. | 12.63 Million USD | 100.0% |
SIGA Technologies, Inc. | 64.21 Million USD | 100.0% |
Tilray Brands, Inc. | 252.08 Million USD | 100.0% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 100.0% |
Shineco, Inc. | 1.58 Million USD | 100.0% |
PetIQ, Inc. | 159.3 Million USD | 100.0% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 100.0% |
Incannex Healthcare Limited | -10.01 Million USD | 100.0% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 100.0% |
Alimera Sciences, Inc. | 1.87 Million USD | 100.0% |
Silver Spike Investment Corp. | - USD | NaN% |
Assertio Holdings, Inc. | 37.68 Million USD | 100.0% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | NaN% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | 100.0% |
Clever Leaves Holdings Inc. | 4.48 Million USD | 100.0% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 100.0% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 100.0% |
Hempacco Co., Inc. | 2.54 Million USD | 100.0% |
Talphera, Inc. | - USD | NaN% |
Alvotech | 74.43 Million USD | 100.0% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 100.0% |
Lantheus Holdings, Inc. | 64.02 Million USD | 100.0% |
Currenc Group, Inc. | 732.91 Thousand USD | 100.0% |
Kamada Ltd. | 87.74 Million USD | 100.0% |
Indivior PLC | 141.79 Million USD | 100.0% |
Evoke Pharma, Inc. | 481.84 Thousand USD | 100.0% |
Flora Growth Corp. | 8.5 Million USD | 100.0% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 100.0% |
Evolus, Inc. | 10.99 Million USD | 100.0% |
HUTCHMED (China) Limited | 50.25 Million USD | 100.0% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 100.0% |
Akanda Corp. | 1.28 Million USD | 100.0% |